Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi ® .
James G Taylor,Sheila Zipfel, Kyla Ramey,Randy Vivian,Adam Schrier,Kapil K Karki,Ashley Katana,Darryl Kato,Tetsuya Kobayashi,Ruben Martinez,Michael Sangi,Dustin Siegel,Chinh V Tran,Zheng-Yu Yang,Jeff Zablocki,Cheng Y Yang,Yujin Wang,Kelly Wang,Katie Chan,Ona Barauskas,Guofeng Cheng,Debi Jin,Brian E Schultz,Todd Appleby,Armando G Villaseñor,John O Link Bioorganic & Medicinal Chemistry Letters（2019）
关键词
Vosevi®,Voxilaprevir,VOX,GS-9857,HCV,Hepatitis C virus,Protein adducts
AI 理解论文
溯源树
样例
